SEMA3D and nonpapillary renal cell carcinoma: Another recent research in our team completed whole-exome sequencing (WES) in 21 ccRCC samples [4] and then annotated single-nucleotide variants of semaphorin 3D (Sema3D) as a potential pathogenic driver mutation by PeCanPie [5].